Disruptive 3D Cell Technology Drives Innovative Diabetes R&D at ADA2019
InSphero CEO Jan Lichtenberg reflects on ADA2019 and how InSphero is enabling T1D and T2D Discovery with our 3D InSight™ Diabetes Discovery Platform. Over the
InSphero CEO Jan Lichtenberg reflects on ADA2019 and how InSphero is enabling T1D and T2D Discovery with our 3D InSight™ Diabetes Discovery Platform. Over the
Microfluidic chips enable researchers to manipulate, image, and analyze small tissue constructs under optimal culturing conditions. Microfluidics, the technology behind emerging body-on-a-chip and organs-on-chips systems,
Pharma companies racing to accelerate drug discovery for chronic liver diseases, such as NASH and fibrosis, need better preclinical testing tools for compound screening and
Correlating human pancreas donor characteristics with 3D InSight™ Islet Microtissue functionality confirms reaggregated islets are a robust, physiologically relevant model for diabetes research. With diabetes
In honor of the inaugural International NASH Day, Insphero explains why we need better preclinical models for non-alcoholic steatohepatitis (NASH) disease drug discovery. Non-alcoholic fatty liver
In their peer-reviewed paper, titled “Utility of spherical human liver microtissues for prediction of clinical drug-induced liver injury”, Will Proctor, Alison Foster, Simon Messner, Dominic Williams, and several other notable experts in the field, published a landmark study comparing 2D and 3D DILI models, highlighting the advantages of using 3D InSight™ Human Liver Microtissues (3D hLiMT) for DILI prediction.
The scientific paper is a highly recommended resource for anyone in the field of Liver Safety
InSphero Akura™ Flow body-on-a-chip technology may help make animal testing in pharma and cosmetic companies obsolete How can we better predict how new drugs act
Ready to unlock the full potential of 3D in vitro? Help us better understand your challenges and interests, and let's get started!
USA and Canada
Phone : +1 908-864-1550
TechPlace, 74 Orion St., Brunswick, ME 04011 USA
Europe and Rest of World
Phone : +41 44 515 04 90
Wagistrasse 27A, 8952, Schlieren, Switzerland
© InSphero. All rights reserved. Privacy Policy | Terms & Conditions | Imprint | Medical Disclaimer | ISO Certification
Fill in form below to contact our 3D in vitro experts
Get the latest news on 3D in vitro research
Fill in the form below to view this resource
"*" indicates required fields